Literature DB >> 21371684

Diagnostic and prognostic value of electrophysiologic study in patients with nondocumented palpitations.

Ermengol Vallès1, Julio Martí-Almor, Victor Bazan, Fabiola Suarez, Debora Cian, Laura Portillo, Jordi Bruguera-Cortada.   

Abstract

The 12-lead electrocardiogram helps to define the arrhythmic mechanism in patients with palpitations. However, in the setting of nondocumented palpitations the value of the electrophysiologic study (EPS) needs additional investigation. We investigated the utility of the EPS in patients with nondocumented palpitations. A total of 172 patients with normal electrocardiographic findings and nondocumented palpitations underwent an EPS. The clinical and electrophysiologic characteristics were assessed. The symptoms were long-lasting (>5 minutes) in 56%. Sudden onset was present in 99%, and termination was rapid in 65%. Neck palpitations were reported in 36%. The EPS findings were normal in 86 patients (50%); atrioventricular nodal reentrant tachycardia was induced in 43, orthodromic reentrant tachycardia in 9, and nonsustained atrial tachycardia/fibrillation (AT/AF) in 34. Long-lasting episodes, sudden termination, and neck palpitations predicted positive EPS findings and were associated with reentrant supraventricular tachycardia (p<0.001). The induction of AT/AF was associated with age >50 years and structural heart disease (p<0.001). After 53 ± 36 months of follow-up, 92% of patients with negative EPS findings were symptom free. Only 32% of patients with induced AT/AF remained free of symptoms (p<0.001). The recurrence of palpitations was more prevalent among patients with structural heart disease and aged >50 years (p<0.001). In conclusion, 50% of patients with nondocumented palpitations had positive EPS findings. A long duration, sudden termination, and neck palpitations, together with structural heart disease and age >50 years, predicted tachycardia inducibility and recurrence and could help in selecting patients suitable for EPS and ablation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21371684     DOI: 10.1016/j.amjcard.2010.12.047

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Ventricular tachyarrhythmia in a 78-year-old woman with essential thrombocythaemia.

Authors:  Mary Rodriguez-Ziccardi; Manolo Rubio; Marvin Lu; Allan Greenspan
Journal:  BMJ Case Rep       Date:  2018-02-08

2.  Factors of negativity of electrophysiological study in children and teenagers complaining of tachycardia and prognostic significance.

Authors:  Béatrice Brembilla-Perrot; Alice Brembilla; Anne Moulin-Zinsch; Jean Marc Sellal; Arnaud Olivier; Vladimir Manenti; Thibaut Villemin; Jean Paul Lethor; Samira Taihï; Joseph Rizk; Marc Rodermann; François Marçon; Nicolas Girerd
Journal:  Pediatr Cardiol       Date:  2014-07-29       Impact factor: 1.655

3.  Contemporary Yield of 24-hour Holter Monitoring: Role of Inter-Atrial Block Recognition.

Authors:  Victor Bazan; German Cediel; Cinta Llibre; Axel Sarrias; Isabel Romeo; Sònia Ibars; Francisco Escudero; Sandra Valdivielso; Felipe Bisbal; Roger Villuendas; Antoni Bayes-Genis; Ferran Padilla
Journal:  J Atr Fibrillation       Date:  2019-08-31

Review 4.  Cardiac monitoring for patients with palpitations.

Authors:  Jaume Francisco-Pascual; Javier Cantalapiedra-Romero; Jordi Pérez-Rodon; Begoña Benito; Alba Santos-Ortega; Jenson Maldonado; Ignacio Ferreira-Gonzalez; Nuria Rivas-Gándara
Journal:  World J Cardiol       Date:  2021-11-26

5.  Cardiovascular safety of anagrelide in healthy subjects: effects of caffeine and food intake on pharmacokinetics and adverse reactions.

Authors:  Manuel Martínez-Sellés; Tomás Datino; Lourdes Figueiras-Graillet; Joubert G Gama; Christopher Jones; Richard Franklin; Francisco Fernández-Avilés
Journal:  Clin Drug Investig       Date:  2013-01       Impact factor: 2.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.